This large Italian multicentre study analysed the clinical spectrum associated with anti-NXP2 antibodies detected by LB, confirming previously described associations, namely skin rash, facial rash, heliotropic rash, periorbital oedema and calcinosis [6, 10, 11]. The gene discussed is MORC3; the disease is Skin rash.